Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,524.00    4.00 (0.26%)
Bid:
1,518.00
Ask:
1,520.00
Spread: 2.00 (0.132%)
Market Cap: £3.21b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Hikma Pharmaceuticals News

LONDON BROKER RATINGS: Goldman Sachs lifts Diageo; Shore cuts Renold
8 Aug 2025

LONDON BROKER RATINGS: Goldman Sachs lifts Diageo; Shore cuts Renold

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

FTSE 100 slips after BoE rate decision, mixed earnings weigh on sentiment
7 Aug 2025

FTSE 100 slips after BoE rate decision, mixed earnings weigh on sentiment

FTSE 100 down 0.7%, FTSE 250 up 0.06% *

LONDON MARKET CLOSE: Stocks mixed, pound up after hawkish BoE rate cut
7 Aug 2025

LONDON MARKET CLOSE: Stocks mixed, pound up after hawkish BoE rate cut

(Alliance News) - The FTSE 100 fell in London on Thursday, while the pound climbed, after the Bank of England lowered interest rates in a tight vote w...

Hikma Pharmaceuticals keeps guidance despite lower core profit at interim
7 Aug 2025

Hikma Pharmaceuticals keeps guidance despite lower core profit at interim

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it continues to expect revenue and profit growth in 2025, despite core operating profit d...

LONDON MARKET OPEN: London mixed ahead of UK interest rate decision
7 Aug 2025

LONDON MARKET OPEN: London mixed ahead of UK interest rate decision

(Alliance News) - London stocks were mixed at Thursday's market open, as investors look to a UK interest rate decision at midday and weigh an accelera...

Hikma on track to meet FY expectations despite H1 operating profit drop
7 Aug 2025

Hikma on track to meet FY expectations despite H1 operating profit drop

(Sharecast News) - Drugmaker Hikma Pharmaceuticals said on Thursday that it was on track to meet FY expectations, with solid top-line growth and stron...